FDA approves Empagliflozin for reducing kidney disease progression in CKD patients Isra Zaman29 Sept 2023 9:45 AM ISTThe U.S. Food and Drug Administration (FDA) has granted approval for empagliflozin 10 mg tablets to reduce the risk of sustained decline in estimated...
Eli Lilly-Boehringer Ingelheim Jardiance gets USFDA approval for adults with chronic kidney disease Ruchika Sharma23 Sept 2023 12:30 PM ISTRidgefield: Eli Lilly and Company and Boehringer Ingelheim have announced that the U.S. Food and Drug Administration (FDA) has approved Jardiance...
FDA Approves Empagliflozin for CKD treatment, regardless of diabetes status Dr. Kamal Kant Kohli23 Sept 2023 10:45 AM ISTThe US Food and Drug Administration has approved another SGLT2 Inhibitor Empagliflozin for treatment of CKD regardless of diabetes status.Jardiance®...
Empagliflozin reduces HF hospitalization and CV death regardless of baseline diuretic doses Dr. Shravani Dali18 Sept 2023 12:00 PM ISTEmpagliflozin reduces HF hospitalization and CV death regardless of baseline diuretic doses suggests a new study published in the JACC: Heart...
Synokem Gets CDSCO Panel Nod to Study Antidiabetic FDC Drug Sitagliptin plus Empagliflozin Dr. Divya Colin3 Sept 2023 6:00 PM ISTNew Delhi: The drug major Synokem Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Eli Lilly- Boehringer Ingelheim Jardiance gets European Commission nod to treat adults with CKD Ruchika Sharma26 July 2023 4:30 PM ISTIngelheim: The European Commission (EC) has approved Jardiance (empagliflozin) for the treatment of adults with chronic kidney disease (CKD),...
Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin Niveditha Subramani4 July 2023 11:15 AM ISTLeft ventricular hypertrophy (LVH) is an established predictor of poor cardiovascular outcomes, while increases in left ventricular mass indexed...
FDA approves new oral therapy for treatment of Type 2 Diabetes in children Dr. Kamal Kant Kohli22 Jun 2023 9:45 AM ISTUSA: The US Food and Drug Administration (FDA) has approved empagliflozin (Jardiance, Boehringer Ingelheim) and empagliflozin combined with metformin...
Eli Lilly-Boehringer Ingelheim bags USFDA nod for Type 2 diabetes drugs Jardiance, Synjardy for children Ruchika Sharma21 Jun 2023 4:30 PM ISTUnited States: The U.S. Food and Drug Administration (FDA) on Tuesday approved Eli Lilly and partner Boehringer Ingelheim's drugs Jardiance and...
Empagliflozin use feasible for HFpEF patients whether or not they are taking diuretics: JAMA Medha Baranwal29 May 2023 11:15 AM ISTUSA: Empagliflozin treatment in patients with heart failure and preserved ejection fraction (HFpEF) is similar regardless of diuretic dose or use; and...
Empagliflozin reduces heart failure events across spectrum of CKD: Analysis of EMPEROR trials Medha Baranwal11 May 2023 10:45 AM ISTUSA: Empagliflozin (Jardiance) consistently reduced heart failure (HF) events across the spectrum of chronic kidney disease (CKD), according to...
Eli Lilly-Boehringer's Jardiance for children with type 2 diabetes accepted by USFDA Ruchika Sharma10 March 2023 12:23 PM ISTIndianapolis: Boehringer Ingelheim and Eli Lilly and Company have announced that the U.S. Food and Drug Administration (FDA) has accepted a...
